Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6403-6411
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6403
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6403
Figure 2 mRNA expression levels measured by real-time PCR for Nucb2 (A), nucb2/nesfatin-1 secretion from tissue explant analyzed by ELISA (B), plasma Nucb2/nesfatin-1 levels (C) obtained from 36-h fasted animals that received i.
p. treatment with AM281 (3 mg/Kg i.p.) (n = 6) or vehicle (n = 6). aP < 0.05 vs control.
- Citation: Folgueira C, Barja-Fernandez S, Prado L, Al-Massadi O, Castelao C, Pena-Leon V, Gonzalez-Saenz P, Baltar J, Baamonde I, Leis R, Dieguez C, Pagotto U, Casanueva FF, Tovar SA, Nogueiras R, Seoane LM. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway. World J Gastroenterol 2017; 23(35): 6403-6411
- URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6403